KLRS Kalaris Therapeutics, Inc. - 8-K

Item 5.07

Submission of Matters to a Vote of Security Holders.

Kalaris Therapeutics, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders on June 3, 2026. The following is a summary of the matters voted on at that meeting.

1.

The stockholders of the Company elected Napoleone Ferrara, M.D., David Hallal and Leone Patterson as Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor has been duly elected and qualified. The results of the stockholders’ vote with respect to such matter were as follows:

For

Withheld

Broker Non-

Votes

Napoleone Ferrara, M.D.

15,619,403

733,571

3,420,470

David Hallal

15,623,189

729,785

3,420,470

Leone Patterson

15,858,093

494,881

3,420,470

2.

The stockholders of the Company approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers. The results of the stockholders’ vote, on a non-binding advisory basis, with respect to such matter were as follows:

For

Against

Abstain

Broker Non-

Votes

15,852,844

495,763

4,366

3,420,470

3.

The stockholders of the Company recommended, on a non-binding advisory basis, that future advisory votes on the compensation of the Company’s named executive officers be held every year. The results of the stockholders’ vote, on a non-binding advisory basis, with respect to such matter were as follows:

One Year

Two

Years

Three

Years

Abstain

Broker Non-

Votes

16,336,117

875

11,154

4,827

3,420,470

After taking into consideration the foregoing voting results, the Board of Directors of the Company intends to hold future advisory votes on the compensation of the Company’s named executive officers every year.

4.

The stockholders of the Company ratified the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of the stockholders’ vote with respect to such matter were as follows:

For

Against

Abstain

19,771,260

1,583

601